Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hepatitis

  Free Subscription


14.09.2026

1 Arch Virol
1 BMC Gastroenterol
2 Gut
1 Hepatology
1 Int J Cancer
1 J Clin Microbiol
3 J Hepatol
3 J Med Virol
2 J Virol
3 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. PAVAN E, Carrasco MM, Pavon JAR, Marin L, et al
    Human pegivirus 1 in healthy blood donors and in acute febrile patients from Mato Grosso, Midwestern Brazil.
    Arch Virol. 2026;171:261.
    PubMed         Abstract available


    BMC Gastroenterol

  2. TAHMAZ A, User U, Kece MS
    Real-world efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir in treatment-naive and treatment-experienced chronic hepatitis c patients: a single-center study.
    BMC Gastroenterol. 2026;26:543.
    PubMed         Abstract available


    Gut

  3. JU B, Liu Z, Yan H, Liu Y, et al
    Characterisation of plasmablast-derived HBsAg-specific antibody and its structural basis for binding to native HBsAg dimer.
    Gut. 2026;75:2028-2043.
    PubMed         Abstract available

  4. DONGELMANS EJ, Patmore LA, Lim SG, Bourliere M, et al
    HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).
    Gut. 2026;75:2000-2008.
    PubMed         Abstract available


    Hepatology

  5. CORNBERG M, Feld JJ
    Stopping is only the beginning: Sequential immune therapy after Nucleos(t)ide analogue withdrawal in chronic hepatitis B.
    Hepatology. 2026 Sep 8. doi: 10.1097/HEP.0000000000001863.
    PubMed        


    Int J Cancer

  6. HE D, Zeng X, Yin L, Liu Y, et al
    Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients.
    Int J Cancer. 2026 Jul 3. doi: 10.1002/ijc.70633.
    PubMed         Abstract available


    J Clin Microbiol

  7. ZHAO T, Peng T, Cui J, Chen Y, et al
    Development and application of a real-time VPCR method for ultra-fast quantitative analysis and Visual Detection of HBV-DNA.
    J Clin Microbiol. 2026;64:e0015426.
    PubMed         Abstract available


    J Hepatol

  8. VO-QUANG E, Lemoine M, Pawlotsky JM
    Barriers to Viral Hepatitis Elimination and New Strategies to Overcome Them in Low- and Middle-Income Countries.
    J Hepatol. 2026 Sep 5:S0168-8278(26)02887-4. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available

  9. DI MARCO L, De Maria N, Lombardo D, Raimondo G, et al
    Post-Transplant Hepatitis D Breakthrough Driven by Integrant-Derived HBsAg from an Extrahepatic HCC Metastasis.
    J Hepatol. 2026 Sep 5:S0168-8278(26)02878-3. doi: 10.1016/j.jhep.2026.
    PubMed        

  10. LIU T, Yang X, Li B, Fan Q, et al
    Mouse models of acute and chronic hepatitis E virus infection.
    J Hepatol. 2026 Sep 11:S0168-8278(26)02891-6. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available


    J Med Virol

  11. COLOMER-CASTELL S, Ibanez-Lligona M, Campos C, Gregori J, et al
    Whole-Genome Analysis of HEV Under Sequential Ribavirin Pressure Reveals Early Minor Variants Predicting Resistance.
    J Med Virol. 2026;98:e71146.
    PubMed         Abstract available

  12. SAXENA A, Maiwall R, Meena BL, Maras JS, et al
    Admission Gut and Plasma-Derived Signatures Associated With Severity and 90-day Outcome in Hepatitis A-Related and Drug-Induced Acute Liver Failure.
    J Med Virol. 2026;98:e71150.
    PubMed         Abstract available

  13. ZEYBEK H, Hosbul T, Gumral R, Sahiner F, et al
    Changes in Anti-HBc Positivity and Antibody Loss in Immunocompromised Patients: An Eight-Year Hospital-Based Analysis From a Tertiary Center in Turkey.
    J Med Virol. 2026;98:e71139.
    PubMed         Abstract available


    J Virol

  14. GOMEZ-ESCOBAR E, Siddique A, Khedr O, Bedard N, et al
    Virus-specific T cells and neutralizing antibodies are independent correlates of long-term protective immunity against hepatitis C virus.
    J Virol. 2026 Sep 10:e0084926. doi: 10.1128/jvi.00849.
    PubMed         Abstract available

  15. LEE J, Chuang Y-C, Lee JA, Ou J-HJ, et al
    Protein kinase D1 regulates innate immune signaling pathways to promote hepatitis C virus replication.
    J Virol. 2026 Sep 9:e0069326. doi: 10.1128/jvi.00693.
    PubMed         Abstract available


    PLoS One

  16. MWAKASUNGURA F, Mwasangama A, Amani D, Bukundi E, et al
    HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022-2023 Tanzania HIV Impact Survey.
    PLoS One. 2026;21:e0358242.
    PubMed         Abstract available

  17. ALDILA D, Rahman NS, Majere A, Fatmawati, et al
    Mathematical modeling of HBV-HDV transmission with superinfection: The role of vaccination and liver transplantation in disease dynamics.
    PLoS One. 2026;21:e0356725.
    PubMed         Abstract available

  18. DAI L, Tan J, Zhou Z, Chen C, et al
    Identification and validation of oxidative stress-related immune signatures in Hepatitis B Virus associated acute liver failure based on WGCNA and machine learning.
    PLoS One. 2026;21:e0356638.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum